2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine, 95.0%, 100mg

Acetamide, N-(2-bromo-5-methoxy-4-methylphenyl)-, 250mg

4,6-Dibromopicolinic acid, 95+%, 100mg

2-(2-Iodophenyl)acetic acid, 97.0%, 100g

D-Leucine, min. 99%, for biochemistry, 5 g, plastic packaging.

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-S-(triphenylmethyl)-D-cysteine>98.0%(HPLC)(T)1g

(R)-2-(Aminomethyl)-3-methylbutanoic acid, 95.0%, 5g

6-BROMO-8-IODOIMIDAZO[1,2-A]PYRIDINE, 95.0%, 1g

Ethyl 3-(4-chlorophenyl)acrylate, 95.0%, 25g

4-amino-1-((2R,3R,4R,5R)-4-((tert-butyldimethylsilyl)oxy)-5-(((tert-butyldiphenylsilyl)oxy)methyl)-5-(chloromethyl)-3-fluorotetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 97%, 250mg

6-Bromo-5-methoxypyridin-3-amine, 95.0%, 250mg

5-Chlorobenzo[d]thiazole-2-thiol, 95.0%, 25g

(Tetrahydrofuran-2-yl)methyl propionate, 95.0%, 25g